IP Library › Granted Patent US 12,590,327
Granted Patent B2
US 12,590,327 · App. 17/048,115 · Granted Mar 31, 2026

Compounds, compositions, and methods for improving assays

Inventors: William Hampton Henley (Chapel Hill, NC); Elizabeth Ann Dethoff (Chapel Hill, NC); John Michael Ramsey (Chapel Hill, NC)
Assignee: The University of North Carolina at Chapel Hill
C12Q1/6818
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,590,327
App. No.
17/048,115
Granted
Mar 31, 2026
Kind
B2
Abstract

Provided are compounds, compositions, kits, systems, devices, and methods for improving an assay such as, for example, a multiplexed PCR assay (e.g., a multiplexed immuno-PCR assay). A solid support (e.g., a bead) may be provided according to some embodiments of the present invention. The solid support may comprise an encoding agent (e.g., a dye), a nucleic acid sequence (e.g., an oligonucleotide and/or primer); and a molecular recognition element (e.g., an antibody). A detection reagent may be provided according to some embodiments of the present invention. The detection reagent may comprise a molecular recognition element (e.g., an antibody) and a nucleic acid tag. In some embodiments, at least a portion of the nucleic acid sequence of the solid support and at least a portion of the nucleic acid target tag of the detection reagent are configured to participate in a nucleic acid amplification process. A solid support and detection reagent may bind to the same target, thereby forming a reagent pair.

Claims (23)

1 . A kit comprising:

(i) a solid support, wherein the solid support comprises:

(a) an encoding agent;

(b) a first nucleic acid sequence, wherein the first nucleic acid sequence comprises a primer that hybridizes to the complement of a second nucleic acid sequence; and

(c) a first molecular recognition element, wherein the first molecular recognition element comprises an antibody or fragment thereof, aptamer, modified aptamer, peptide, protein, carbohydrate, and/or combinations thereof,

wherein the first nucleic acid sequence is attached to the solid support via a photocleavable or heat labile bond; and

wherein the solid support does not comprise a primer that hybridizes to the second nucleic acid sequence; and

(ii) a detection reagent comprising a second molecular recognition element, wherein the second molecular recognition element comprises an antibody or fragment thereof, aptamer, modified aptamer, peptide, protein, carbohydrate, and/or combinations thereof, and the second nucleic acid sequence, wherein the second nucleic acid sequence comprises a nucleic acid tag comprising at least a first portion and a second portion, wherein the first portion of the second nucleic acid sequence is substantially identical to the primer in the first nucleic acid sequence,

wherein the first nucleic acid sequence and second nucleic acid sequence comprise single stranded-DNA; and

wherein the primer in the first nucleic acid sequence and at least the first portion of the second nucleic acid sequence are configured to participate in a nucleic acid amplification process, wherein the nucleic acid amplification process is polymerase chain reaction (PCR) configured to amplify the nucleic acid tag.

2 . The kit of claim 1 , wherein the solid support further comprises a linker and the linker is on the surface of the solid support and wherein the first molecular recognition element and/or the first nucleic acid sequence is/are attached to the linker.

3 . The kit of claim 1 , wherein the first nucleic acid sequence and/or the first molecular recognition element is/are attached to the solid support via a heat labile bond.

4 . The kit of claim 1 , wherein the first nucleic acid sequence comprises about 10 nucleotides to about 60 nucleotides.

5 . The kit of claim 1 , wherein the second nucleic acid sequence comprises about 20 nucleotides to about 300 nucleotides.

6 . The kit of claim 1 , wherein the second nucleic acid sequence is covalently attached to the second molecular recognition element.

7 . The kit of claim 1 , further comprising an amplification agent.

8 . The kit of claim 7 , wherein the amplification agent has a primer that (i) hybridizes to the second nucleic acid sequence and (ii) is complementary to the second portion of the second nucleic acid sequence.

9 . The kit of claim 8 , wherein the second portion of the second nucleic acid sequence is in the 3′ region of the second nucleic acid sequence.

10 . The kit of claim 1 , wherein the first portion of the second nucleic acid sequence comprises at least 5 nucleotides and the primer in the first nucleic acid sequence comprises at least 5 nucleotides.

11 . The kit of claim 1 , wherein the first portion of the second nucleic acid sequence is present in the 5′ region of the second nucleic acid sequence.

12 . The kit of claim 1 , wherein the second molecular recognition element is an antibody and the second nucleic acid sequence is attached to one or more amino acid(s) of the antibody.

13 . The kit of claim 12 , wherein the second nucleic acid sequence is covalently attached to the fragment crystallizable (Fc) region of the antibody.

14 . The kit of claim 1 , wherein the first molecular recognition element is attached to the solid support via a photocleavable or heat labile bond.

Assignments (2)
SECURITY INTEREST Recorded May 13, 2026
From: CODETTA BIO INC.
To: ANZU INDUSTRIAL CAPITAL PARTNERS III, L.P.; AICP III LP; ANZU INDUSTRIAL CAPITAL PARTNERS III QP, L.P.
Reel/Frame 074645/0206 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2021
From: HENLEY, WILLIAM HAMPTON; DETHOFF, ELIZABETH ANN; RAMSEY, JOHN MICHAEL
To: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
Reel/Frame 054879/0678 →
Continuity (2)
Provisional Application 62736525 · Sep 26, 2018
Related Publication 20210214776A1 · Jul 15, 2021
References Cited (95)
US 6143496A · Brown et al. · 2000 [cited by applicant]
US 6387331B1 · Hunter · 2002 [cited by applicant]
US 6716629B2 · Hess et al. · 2004 [cited by applicant]
US 6743633B1 · Hunter · 2004 [cited by applicant]
US 6893877B2 · Hunter et al. · 2005 [cited by applicant]
US 7332271B2 · Okeefe et al. · 2008 [cited by applicant]
US 7547556B2 · Hunter et al. · 2009 [cited by applicant]
US 8029745B2 · Hunter et al. · 2011 [cited by applicant]
US 8222047B2 · Duffy et al. · 2012 [cited by applicant]
US 8236574B2 · Duffy et al. · 2012 [cited by applicant]
US 8415171B2 · Rissin et al. · 2013 [cited by applicant]
US 8460878B2 · Walt et al. · 2013 [cited by applicant]
US 8460879B2 · Walt et al. · 2013 [cited by applicant]
US 8492098B2 · Walt et al. · 2013 [cited by applicant]
US 8846415B2 · Duffy et al. · 2014 [cited by applicant]
US 9110025B2 · Rissin et al. · 2015 [cited by applicant]
US 9211537B2 · Hansen et al. · 2015 [cited by applicant]
US 9310360B2 · Duffy et al. · 2016 [cited by applicant]
US 9329174B2 · Noji et al. · 2016 [cited by applicant]
US 9395359B2 · Walt et al. · 2016 [cited by applicant]
US 9482662B2 · Duffy et al. · 2016 [cited by applicant]
US 9551663B2 · Rissin et al. · 2017 [cited by applicant]
US 9617589B2 · Ramsey et al. · 2017 [cited by applicant]
US 9678068B2 · Duffy et al. · 2017 [cited by applicant]
US 9846155B2 · Rissin et al. · 2017 [cited by applicant]
US 20020094533A1 · Hess et al. · 2002 [cited by applicant]
US 20050239108A1 · Barletta et al. · 2005 [cited by applicant]
US 20070059690A1 · Islam et al. · 2007 [cited by applicant]
US 20120196774A1 · Fournier et al. · 2012 [cited by applicant]
US 20130059741A1 · Weiner · 2013 [cited by applicant]
US 20130176767A1 · Brooks · 2013 [cited by applicant]
US 20130345078A1 · Walt et al. · 2013 [cited by applicant]
US 20130345088A1 · Noji et al. · 2013 [cited by applicant]
US 20140094386A1 · Wilson et al. · 2014 [cited by applicant]
US 20140272939A1 · Aghvanyan · 2014 [cited by examiner]
US 20150211048A1 · Ramsey et al. · 2015 [cited by applicant]
US 20150353997A1 · Duffy et al. · 2015 [cited by applicant]
US 20160060687A1 · Zhu · 2016 [cited by examiner]
US 20160123969A1 · Rissin et al. · 2016 [cited by applicant]
US 20170038390A1 · Walt et al. · 2017 [cited by applicant]
US 20170160292A1 · Wilson et al. · 2017 [cited by applicant]
US 20170234882A9 · Wilson et al. · 2017 [cited by applicant]
US 20180003703A1 · Duffy et al. · 2018 [cited by applicant]
US 20180017552A1 · Duffy et al. · 2018 [cited by applicant]
US 20180037614A1 · Pollock et al. · 2018 [cited by applicant]
US 20180163270A1 · Mcdowell-Buchanan et al. · 2018 [cited by applicant]
EP 2224015A1 · 2010 [cited by applicant]
EP 1996717B1 · 2014 [cited by applicant]
EP 2538220B1 · 2016 [cited by applicant]
JP 2008500047A · 2008 [cited by applicant]
JP 2010193884A · 2010 [cited by applicant]
JP 2016512429A · 2016 [cited by applicant]
JP 2017515469A · 2017 [cited by applicant]
WO 2005003394A2 · 2005 [cited by applicant]
WO 2007098148A2 · 2007 [cited by applicant]
WO 2011143583A1 · 2011 [cited by applicant]
WO 2013176767 · 2013 [cited by applicant]
WO 2014165061A1 · 2014 [cited by applicant]
WO 2014182835 · 2014 [cited by applicant]
WO 2015070037A2 · 2015 [cited by applicant]
WO 2015164212A1 · 2015 [cited by applicant]
WO 2017015529 · 2017 [cited by applicant]
WO 2017065854 · 2017 [cited by applicant]
WO WO2017070309A1 · 2017 [cited by examiner]
WO 2017112025 · 2017 [cited by applicant]
WO WO2017112025A2 · 2017 [cited by examiner]
WO 2020068174 · 2020 [cited by applicant]
WO 2020162996 · 2020 [cited by applicant]
Kim, Multiplex real-time PCR using temperature sensitive primer-supplying hydrogel particles and its application for malaria species identification, PLoS ONE, 13(1): e0190451, 2018. (Year: 2018). [cited by examiner]
International Search Report and the Written Opinion of the International Searching Authority corresponding to International Patent Application No. PCT/US2019/052622 (13 pages) (mailed Jul. 14, 2020). [cited by applicant]
Malou et al. “Immuno-PCR: a promising ultrasensitive diagnostic method to detect antigens and antibodies” Trends in Microbiology, 19(6):295-302 (2011). [cited by applicant]
Spiro et al. “A Bead-Based Method for Multiplexed Identification and Quantitation of DNA Sequences Using Flow Cytometry” Applied and Environmental Microbiology, 66(10):4258-4265 (2000). [cited by applicant]
Chang et al. “Immuno-PCR: an ultrasensitive immunoassay for biomolecular detection” Analytica Chimica Acta, 910:12-24 (2016) (Abstract only). [cited by applicant]
Diehl et al. “BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions” Nature Methods, 3:551-559 (2006) (Abstract only). [cited by applicant]
Hendrickson et al. “High sensitivity multianalyte immunoassay using covalent DNA-labeled antibodies and polymerase chain reaction” Nucleic Acids Research, 23(3):522-529 (1995). [cited by applicant]
Hinz et al. “Polymer support for exonucleolytic sequencing” Journal of Biotechnology, 86:281-288 (2001). [cited by applicant]
Huang et al. “Highly sensitive mutation detection based on digital amplification coupled with hydrogel bead-array” Chemical Communications, 27:4094-4096 (2009). [cited by applicant]
Kalinina et al. “Nanoliter scale PCR with TaqMan detection” Nucleic Acids Research, 25(10):1999-2004 (1997). [cited by applicant]
Kan et al. “Isolation and detection of single molecules on paramagnetic beads using sequential fluid flows in microfabricated polymer array assemblies” Lab on a Chip, 12:977-985 (2012). [cited by applicant]
Leamon et al. “A massively parallel PicoTiterPlate™ based platform for discrete picoliter-scale polymerase chain reactions” Electrophoresis, 24:3769-3777 (2003). [cited by applicant]
Lind et al. “Development and evaluation of three real-time immuno-PCR assemblages for quantification of PSA” Journal of Immunological Methods, 304:107-116 (2005). [cited by applicant]
Lizardi et al. “Mutation detection and single-molecule counting using isothermal rolling-circle amplification” Nature Genetics, 19:225-232 (1998). [cited by applicant]
Margulies et al. “Genome sequencing in microfabricated high-density picolitre reactors” Nature, 437:376-380 (2005). [cited by applicant]
Nagai et al. “Development of a Microchamber Array for Picoliter PCR” Analytical Chemistry, 73(5):1043-1047 (2001). [cited by applicant]
Nam et al. “Nanoparticle-Based Bio-Bar Codes for the Ultrasensitive Detection of Proteins” Science, 301:1884-1886 (2003). [cited by applicant]
Osborne et al. “Single-Molecule Analysis of DNA Immobilized on Microspheres” Analytical Chemistry, 72:3678-3681 (2000). [cited by applicant]
Rissin et al. “Simultaneous Detection of Single Molecules and Singulated Ensembles of Molecules Enables Immunoassays with Broad Dynamic Range” Analytical Chemistry, 83:2279-2285 (2011). [cited by applicant]
Rissin et al. “Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations” Nature Biotechnology, 28(6):595-599 (2010). [cited by applicant]
Rissin, David M. “Single Molecule Detection: Analytical Applications and Fundamental Studies”, Dissertation, Tufts University, 183 pages (Apr. 2007). [cited by applicant]
Ruzicka et al. “Immuno-PCR with a Commercially Available Avidin System” Science, 260(5108):698-699 (1993). [cited by applicant]
Sano et al. “Immuno-PCR: Very Sensitive Antigen Detection by Means of Specific Antibody—DNA Conjugates” Science, 258(5079):120-122 (1992). [cited by applicant]
Tan et al. “Monitoring the Reactions of Single Enzyme Molecules and Single Metal Ions” Analytical Chemistry, 69:4242-4248 (1997). [cited by applicant]
Zhou et al. “Universal immuno-PCR for ultra-sensitive target protein detection” Nucleic Acids Research, 21(25):6038-6039 (1993). [cited by applicant]
Extended European Search Report corresponding to European Patent Application No. 19898938.6 (12 pages) (dated Jun. 9, 2022). [cited by applicant]
Japanese Office Action corresponding to Japanese Application No. 2020-558006; mailed Jan. 9, 2024 (Foreign text 6 pages, English Translation thereof 6 pages). [cited by applicant]